PlayAGS (AGS) Posts Breakeven Q4 Earnings, Tops on Revenues
https://www.zacks.com/stock/news/2236794/playags-ags-posts-breakeven-q4-earnings-tops-on-revenues?cid=CS-ZC-FT-analyst_blog|earnings_article-2236794
Mar 06, 2024 - PlayAGS' (AGS) fourth-quarter 2023 results reflect double-digit growth across all three operating segments.
0
Time to Buy into Target's (TGT) Post Earnings Rally?
https://www.zacks.com/stock/news/2236363/time-to-buy-into-target-s-tgt-post-earnings-rally?cid=CS-ZC-FT-stocks_in_the_news-2236363
Mar 05, 2024 - Target (TGT) headlined Tuesday's trading session with its stock spiking +12% after exceeding fourth quarter expectations this morning.
0
GitLab (GTLB) Posts Gain in Q4, Beats Revenue Estimates
https://www.zacks.com/stock/news/2236154/gitlab-gtlb-posts-gain-in-q4-beats-revenue-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2236154
Mar 05, 2024 - GitLab's (GTLB) fiscal fourth-quarter results benefit from solid subscription revenue growth driven by expanding clientele.
0
Victoria's Secret (VSCO) to Post Q4 Earnings: What's in Store?
https://www.zacks.com/stock/news/2235960/victoria-s-secret-vsco-to-post-q4-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2235960
Mar 05, 2024 - Victoria's Secret's (VSCO) fourth-quarter 2023 results are likely to benefit from high demand in China.
0
CASI Pharma Posts Positive BI-1206 Interim Phase 1 Data In R/R INHL; Stock Climbs In Pre-market
https://www.rttnews.com/story.aspx?Id=3429895
Mar 05, 2024 - Shares of CASI Pharmaceuticals, Inc. (CASI) were gaining more than 49 percent in pre-market activity on Nasdaq after the biopharmaceutical company announced Tuesday positive interim Phase 1 Data for BI-1206 (Anti-FcyRIIB antibody) in patients with relapsed/refractory or R/R indolent Non-Hodgkin's Lymphoma or iNHL.
0
PlayAGS (AGS) Gears Up to Post Q4 Earnings: What's in Store?
https://www.zacks.com/stock/news/2235402/playags-ags-gears-up-to-post-q4-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2235402
Mar 04, 2024 - PlayAGS' (AGS) fourth-quarter 2023 results are likely to be aided by high contributions from all its operational segments. However, high costs might impact growth.
0
Is Post Holdings (POST) a Great Value Stock Right Now?
https://www.zacks.com/stock/news/2234580/is-post-holdings-post-a-great-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2234580
Mar 01, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Hormel Foods (HRL) Q1 Earnings & Sales Beat Estimates, Up Y/Y
https://www.zacks.com/stock/news/2234525/hormel-foods-hrl-q1-earnings-sales-beat-estimates-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2234525
Mar 01, 2024 - Hormel Foods' (HRL) first-quarter fiscal 2024 results reflect increased sales and earnings on the back of the solid Foodservice segment.
0
AeroVironment (AVAV) to Post Q3 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2234522/aerovironment-avav-to-post-q3-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2234522
Mar 01, 2024 - AeroVironment's (AVAV) fiscal Q3 results are likely to reflect solid sales from its Unmanned Systems segment amid lower service sales and higher selling, general and administrative expenses.
0
Abercrombie (ANF) to Post Q4 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2234503/abercrombie-anf-to-post-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2234503
Mar 01, 2024 - Abercrombie's (ANF) fourth-quarter fiscal 2023 results are likely to show gains from lower freight costs and brand strength.
0